FDA Submits Proposed Collection of Information for Review and Clearance

Summary

The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, related to a toll-free number for consumer reporting of drug product side effects in direct-to-consumer television advertisements for prescription drugs.